Natus Medical To Divest Medix For Focusing On Core Business
Zacks Investment Research | Apr 07, 2019 10:13PM ET
In a bid to focus on the core, profitable part of its business, Natus Medical Incorporated (NASDAQ:BABY) recently decided to sell its wholly-owned subsidiary, Medix Medical Devices, which the company had acquired in 2010. Per this announcement, the company has signed a definitive agreement to divest Medix in an employee-led buyout.
Financial terms of the deal have been kept under wraps.
Going by the deal details, incubators, warmers and other Medix products will be divested. Under this new ownership, Medix will continue to distribute Medix products and the previously distributed line of Natus Medical products plus other third-party products in Argentina and Venezuela.
According to Natus Medical, this deal is strategically aligned with its business as apart from enabling it to refocus on the core products, this decision will permit it to plan investment in the high-growth markets.
We believe, this move is integral to the company’s recent implementation of a new organizational structure, designed to improve its operational performance.
Financial Impact of the Sell-Off
Medix recorded approximately $7.6 million of revenues in 2018 and was expected to contribute approximately $6 million to its top line in 2019.
Natus Medical projects this divestiture to be accretive to its operating margin going forward. The company expects to incur $3-$4 million of transaction and disposal expenses as part of the divestment.
The company will provide an updated full-year revenue guidance after adjusting the impact of the divestiture during first-quarter 2019 earnings release.
Organizational Restructuring at a Glance
Natus Medical is progressing well with its new organisational streamlining process wherein it is working on consolidating its three business units, namely Neuro, Newborn Care and Otometrics into “One Natus”.
Per the company, this initiative creates a single, unified entity with the globally led functional teams in Sales & Marketing, Manufacturing, R&D, Quality plus General and Administrative departments. The company claims this structure to increase transparency, efficiency and cross-functional collaboration across common technologies, processes and customer channels.
The new organization is expected to optimize Natus Medical’s proven go-to-market strategies and leverage its common engineering, operations and supply chain infrastructure.
Share Price Performance
In the past year, Natus Medical has underperformed its Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.